/Companies

Nouscom

15 known investors

Find your way into Nouscom

Sign up to find every way you can get introduced to Nouscom

  • Your email: who you already know at Nouscom, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Nouscom team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Immunotherapy company developing NOUS-209 for the prevention of Lynch syndrome-associated cancers.

Investors · 15

M Ventureslisted by M VenturesLos Angeles · $10.8M

How we know: a partner's Signal profile · globenewswire.com · the VCSheet dataset · Not right? Tell us

Also in the syndicate · 3

LSPPanakès PartnersXGen Ventures

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Nouscom do?
Immunotherapy company developing NOUS-209 for the prevention of Lynch syndrome-associated cancers.
Who are Nouscom's investors?
Nouscom's investors include 5AM Ventures, Andera Partners, Angelini Ventures, CDP Venture Capital, Indaco Venture Partners, M Ventures, Revelation Partners, XGEN Venture and 4 more.